Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trade Group Efforts, Timing Bring AER System Concerns To Fore

This article was originally published in The Tan Sheet

Executive Summary

Congressional and industry cooperation over a broad dietary supplement/OTC drug adverse event reporting system is the result of long-term lobbying combined with recent momentum spurred by widespread safety concerns

You may also be interested in...

Senators Durbin, Hatch To Work Together On AER Plan

Dietary supplement industry critic Sen. Richard Durbin (D-Ill.) will work alongside congressional industry supporters to develop legislation to create a mandatory serious adverse event reporting system

Pediatric Supplement Hearing Planned In House; Durbin Slams DSHEA

The House Energy & Commerce/Oversight & Investigations subcommittee is planning a hearing on dietary supplements for obesity in children June 16

Serious Herbal AEs Deemed Negligible; AHPA Urges Mandatory Reporting

Mandatory adverse event reporting would not harm the botanicals industry because the number of serious adverse events for such products is extremely small, AHPA's board has concluded


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts